VANDA PHARMACEUTICALS ($VNDA) posted quarterly earnings results on Wednesday, May 7th. The company reported earnings of -$0.50 per share, beating estimates of -$0.61 by $0.11. The company also reported revenue of $50,040,000, beating estimates of $46,037,016 by $4,002,984.
You can see Quiver Quantitative's $VNDA stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
VANDA PHARMACEUTICALS Insider Trading Activity
VANDA PHARMACEUTICALS insiders have traded $VNDA stock on the open market 11 times in the past 6 months. Of those trades, 10 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $VNDA stock by insiders over the last 6 months:
- MIHAEL HRISTOS POLYMEROPOULOS (President and CEO) has made 9 purchases buying 60,000 shares for an estimated $287,840 and 0 sales.
- STEPHEN RAY MITCHELL sold 5,000 shares for an estimated $25,863
- KEVIN PATRICK MORAN (SVP, CFO & Treasurer) purchased 2,000 shares for an estimated $8,778
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
VANDA PHARMACEUTICALS Hedge Fund Activity
We have seen 69 institutional investors add shares of VANDA PHARMACEUTICALS stock to their portfolio, and 73 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NANTAHALA CAPITAL MANAGEMENT, LLC removed 1,593,516 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $7,632,941
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 959,807 shares (-67.1%) from their portfolio in Q4 2024, for an estimated $4,597,475
- MORGAN STANLEY added 724,082 shares (+117.5%) to their portfolio in Q4 2024, for an estimated $3,468,352
- KRENSAVAGE ASSET MANAGEMENT, LLC removed 314,352 shares (-75.8%) from their portfolio in Q4 2024, for an estimated $1,505,746
- SCHONFELD STRATEGIC ADVISORS LLC added 270,541 shares (+inf%) to their portfolio in Q4 2024, for an estimated $1,295,891
- MILLENNIUM MANAGEMENT LLC added 269,183 shares (+67.4%) to their portfolio in Q4 2024, for an estimated $1,289,386
- D. E. SHAW & CO., INC. removed 255,652 shares (-45.7%) from their portfolio in Q4 2024, for an estimated $1,224,573
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
VANDA PHARMACEUTICALS Government Contracts
We have seen $162,771 of award payments to $VNDA over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- HETLIOZ - BULK: $162,771
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
